| 000 | 01768 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515230354.0 | ||
| 264 | 0 | _c20100902 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1475-2875 | ||
| 024 | 7 |
_a10.1186/1475-2875-9-175 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOuattara, Amed | |
| 245 | 0 | 0 |
_aLack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. _h[electronic resource] |
| 260 |
_bMalaria journal _cJun 2010 |
||
| 300 |
_a175 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aAluminum Hydroxide |
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aAntigens, Protozoan _xgenetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aHaplotypes _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization |
| 650 | 0 | 4 |
_aMalaria Vaccines _xadverse effects |
| 650 | 0 | 4 |
_aMalaria, Falciparum _xparasitology |
| 650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
| 650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aProtozoan Proteins _xgenetics |
| 700 | 1 | _aMu, Jianbing | |
| 700 | 1 | _aTakala-Harrison, Shannon | |
| 700 | 1 | _aSaye, Renion | |
| 700 | 1 | _aSagara, Issaka | |
| 700 | 1 | _aDicko, Alassane | |
| 700 | 1 | _aNiangaly, Amadou | |
| 700 | 1 | _aDuan, Junhui | |
| 700 | 1 | _aEllis, Ruth D | |
| 700 | 1 | _aMiller, Louis H | |
| 700 | 1 | _aSu, Xin-zhuan | |
| 700 | 1 | _aPlowe, Christopher V | |
| 700 | 1 | _aDoumbo, Ogobara K | |
| 773 | 0 |
_tMalaria journal _gvol. 9 _gp. 175 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1475-2875-9-175 _zAvailable from publisher's website |
| 999 |
_c19914594 _d19914594 |
||